CoChat
Sign Up
Cited by 49

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Cholesterol-Lowering Agents: Statins—For Everyone?

Hadjiphilippou, Savvas, Ray, Kausik K.·2019·Circulation Research
DOI 10.1161/circresaha.118.313245
Open this paper in CoChat — free account

Abstract

Cardiovascular disease (CVD) remains the leading cause of death worldwide. To date, decades of research has established LDL-C (low-density lipoprotein cholesterol) as a causal factor in the development of atherosclerotic CVD. Statin therapy, supported by a broad evidence base, has demonstrated its superior efficacy in reducing LDL-C and subsequent cardiovascular risk. It therefore currently forms the mainstay of lipid-lowering therapy as recommended by international guidelines. Statin therapy is indicated in the secondary prevention of atherosclerotic CVD, as well as genetic causes of dyslipidemia (such as familial hypercholesterolemia). Although this strategy targets those most at risk, it merely addresses those most susceptible and does not account for the fact that most cardiovascular events occur in those at moderate to low risk. In addition, there is evidence for use in primary prevention such as in those with diabetes mellitus, chronic kidney disease, and high risk of future atherosclerotic CVD as determined by risk prediction calculators. Risk prediction tools, however, are far from perfect and do not accurately account for those at low short-term but high lifelong risk. Considering the log-linear relationship between LDL-C reductions and reductions in risk of atherosclerotic CVD, even in those at very low risk of future events, a clinical question posed is can we and should we shift the entire risk distribution by treating everyone? The present review discusses these issues in more detail outlining arguments for and against each approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.118.313245

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 73

  1. 10.1016/S0140-6736(04)17018-9 · DOI · Paper page
  2. 10.2183/pjab.86.484 · DOI
  3. 10.1016/0014-5793(76)80996–9 · DOI
  4. 10.1016/j.atherosclerosissup.2004.08.027 · DOI
  5. 10.1056/NEJM199511163332001 · DOI · Paper page
  6. 10.1016/S0140-6736(02)09327-3 · DOI · Paper page
  7. 10.1056/NEJMoa0807646 · DOI · Paper page
  8. 10.1093/eurheartj/ehx144 · DOI · Paper page
  9. 10.1016/S0140-6736(12)60367-5 · DOI · Paper page
  10. 10.1177/2047487316653709 · DOI
  11. 10.1093/eurheartj/ehv043 · DOI · Paper page
  12. 10.1093/eurheartj/ehy182 · DOI · Paper page
  13. 10.1016/j.jacc.2013.11.002 · DOI · Paper page
  14. 10.1056/NEJM199811053391902 · DOI · Paper page
  15. 10.1056/NEJM199610033351401 · DOI · Paper page
  16. 10.1001/jama.285.13.1711 · DOI · Paper page
  17. 10.1001/jama.294.19.2437 · DOI · Paper page
  18. 10.1161/CIRCULATIONAHA.117.032615 · DOI
  19. 10.1016/j.jacc.2004.07.053 · DOI
  20. 10.1016/S0140-6736(05)67394-1 · DOI · Paper page
  21. 10.1016/S0140-6736(10)61350–5 · DOI · Paper page
  22. 10.1093/eurheartj/eht273 · DOI · Paper page
  23. 10.1016/j.atherosclerosis.2015.09.021 · DOI
  24. 10.1136/bmj.303.6807.893 · DOI · Paper page
  25. 10.1001/archinte.158.6.655 · DOI
  26. 10.1161/CIRCULATIONAHA.115.018383 · DOI
  27. 10.1161/CIRCULATIONAHA.116.022335 · DOI
  28. 10.7326/M17-0681 · DOI
  29. 10.1136/hrt.2007.140905 · DOI
  30. 10.1001/jama.279.20.1615 · DOI · Paper page
  31. Chou, R, Dana, T, Blazina, I, Daeges, M, Bougatsos, C, Grusing, S, Jeanne, TL. Statin use for the prevention of cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US); November 2016.
  32. 10.1002/14651858.CD004816.pub5 · DOI · Paper page
  33. 10.1093/ije/14.1.32 · DOI · Paper page
  34. 10.1016/S0140-6736(10)60674–5 · DOI · Paper page
  35. 10.1056/NEJMoa041365 · DOI
  36. 10.1093/eurheartj/ehx209 · DOI
  37. 10.1016/S0140-6736(11)60739-3 · DOI · Paper page
  38. 10.1056/NEJMoa043545 · DOI · Paper page
  39. 10.1161/01.CIR.100.10.1134 · DOI · Paper page
  40. 10.2337/diab.23.2.105 · DOI · Paper page
  41. 10.2337/diacare.16.2.434 · DOI · Paper page
  42. 10.1016/0735-1097(89)90053-3 · DOI
  43. 10.1016/S0140-6736(10)60484–9 · DOI · Paper page
  44. 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
  45. 10.1016/S0140-6736(08)60104-X · DOI · Paper page
  46. 10.2337/dc05-2415 · DOI · Paper page
  47. 10.1111/j.1076-7460.2003.02000.x · DOI
  48. 10.1161/CIRCULATIONAHA.117.028271 · DOI
  49. 10.1016/j.amjcard.2005.09.142 · DOI
  50. 10.1016/j.amjcard.2004.01.039 · DOI
  51. 10.1093/eurheartj/ehv072 · DOI · Paper page
  52. 10.1136/bmj.303.6797.276 · DOI
  53. 10.1371/journal.pone.0029849 · DOI
  54. 10.1016/j.cjca.2010.12.024 · DOI
  55. 10.1007/s11606-008-0636-7 · DOI
  56. 10.1016/S0140-6736(17)31075-9 · DOI · Paper page
  57. 10.1001/jama.2016.3608 · DOI · Paper page
  58. 10.7326/0003-4819-158-7-201304020-00004 · DOI · Paper page
  59. 10.1016/j.ahj.2013.06.004 · DOI · Paper page
  60. 10.1161/CIRCULATIONAHA.111.055269 · DOI
  61. 10.1016/j.jacc.2010.10.047 · DOI · Paper page
  62. 10.1016/S2213-8587(14)70173-1 · DOI · Paper page
  63. 10.1161/CIRCULATIONAHA.107.699579 · DOI · Paper page
  64. 10.1016/j.jacc.2016.02.055 · DOI
  65. 10.7326/M14-1281 · DOI
  66. 10.1001/jama.2014.2632 · DOI
  67. 10.1161/CIRCULATIONAHA.110.986349 · DOI
  68. 10.7326/0003-4819-150-4-200902170-00005 · DOI
  69. 10.1161/CIRCULATIONAHA.117.027067 · DOI
  70. 10.1136/bmj.38993.731725.BE · DOI
  71. 10.1016/j.amjcard.2009.09.025 · DOI
  72. 10.1016/j.jacc.2009.08.035 · DOI
  73. 10.1016/j.jacc.2009.10.005 · DOI

Cited by

Sorted by citations

Metadata

Authors
Hadjiphilippou, S., & Ray, K. K.
Venue
Circulation Research
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2019-02
Volume
124
Issue
3
Pages
354-363
ISSN
  • 0009-7330
  • 1524-4571
DOI
10.1161/circresaha.118.313245
Cited by
49
References
25
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review